172 related articles for article (PubMed ID: 29335942)
1. [Lipoprotein (a) - what to do?].
Waldmann E
MMW Fortschr Med; 2018 Jan; 160(1):46-49. PubMed ID: 29335942
[No Abstract] [Full Text] [Related]
2. Apolipoprotein(a) Antisense Oligonucleotides: A New Treatment Option for Lowering Elevated Lipoprotein(a)?
Schreml J; Gouni-Berthold I
Curr Pharm Des; 2017; 23(10):1562-1570. PubMed ID: 28128058
[TBL] [Abstract][Full Text] [Related]
3. Editorial: Lipoprotein (a), More than Just Cholesterol?
Kolovou GD; Katsiki N; Mikhailidis DP
Curr Med Chem; 2017; 24(10):952-956. PubMed ID: 28571555
[No Abstract] [Full Text] [Related]
4. Lipoprotein(a) and cardiovascular risk in adult Mexicans.
Cardoso-Saldaña G; Ize-Lema I; Kimura LY; Zamora González J; Posadas Romero C
Rev Invest Clin; 1997; 49(2):85-92. PubMed ID: 9294956
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a): the underestimated cardiovascular risk factor.
Thompson GR; Seed M
Heart; 2014 Apr; 100(7):534-5. PubMed ID: 24153415
[No Abstract] [Full Text] [Related]
6. Lipoprotein(a) in 505 hospitalized patients with various pathological states: correlations with cardiovascular diseases and therapies.
Constans J; Wendling G; Peuchant E; Camilleri G; Conri C
Int Angiol; 1996 Mar; 15(1):1-5. PubMed ID: 8739528
[TBL] [Abstract][Full Text] [Related]
7. New risk factors for atherosclerosis and patient risk assessment.
Fruchart JC; Nierman MC; Stroes ES; Kastelein JJ; Duriez P
Circulation; 2004 Jun; 109(23 Suppl 1):III15-9. PubMed ID: 15198961
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between body mass index, lipoprotein (a) level and positive family history of cardiovascular diseases in children and adolescents with obesity, hypertension and diabetes].
Głowińska B; Urban M; Koput A
Pol Merkur Lekarski; 2002 Feb; 12(68):108-14. PubMed ID: 11995245
[TBL] [Abstract][Full Text] [Related]
9. Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease.
Stein EA; Raal F
Cardiovasc Drugs Ther; 2016 Feb; 30(1):101-8. PubMed ID: 26861250
[TBL] [Abstract][Full Text] [Related]
10. Does regular lipid apheresis in patients with isolated elevated lipoprotein(a) levels reduce the incidence of cardiovascular events?
Rosada A; Kassner U; Vogt A; Willhauck M; Parhofer K; Steinhagen-Thiessen E
Artif Organs; 2014 Feb; 38(2):135-41. PubMed ID: 23889507
[TBL] [Abstract][Full Text] [Related]
11. Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study).
Waldmann E; Vogt A; Crispin A; Altenhofer J; Riks I; Parhofer KG
Atherosclerosis; 2017 Apr; 259():20-25. PubMed ID: 28279833
[TBL] [Abstract][Full Text] [Related]
12. [Semiologic value of LDL cholesterol and apolipoprotein B in risk of atherosclerosis].
Frey J; Couderc R
Ann Biol Clin (Paris); 1998; 56(5):517-20. PubMed ID: 9769517
[No Abstract] [Full Text] [Related]
13. Serum lipoprotein (a) as a risk factor for thoracic aortic atherosclerosis in subjects aged > 40 years.
Nishino M; Ito T; Yasuno M; Kuryu T; Yamada Y; Abe H; Hori M; Kamada T
Am J Cardiol; 1993 Jul; 72(2):227-9. PubMed ID: 8328390
[No Abstract] [Full Text] [Related]
14. The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years on.
Schettler VJJ; Neumann CL; Peter C; Zimmermann T; Julius U; Roeseler E; Heigl F; Grützmacher P; Blume H; Vogt A;
Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):44-49. PubMed ID: 28233268
[TBL] [Abstract][Full Text] [Related]
15. Latest developments in the treatment of lipoprotein (a).
Bos S; Yayha R; van Lennep JE
Curr Opin Lipidol; 2014 Dec; 25(6):452-60. PubMed ID: 25318824
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein (a) level in the population in Taiwan: relationship to sociodemographic and atherosclerotic risk factors.
Chien KL; Lee YT; Sung FC; Su TC; Hsu HC; Lin RS
Atherosclerosis; 1999 Apr; 143(2):267-73. PubMed ID: 10217355
[TBL] [Abstract][Full Text] [Related]
17. Highlights of the 83rd European Atherosclerosis Society (EAS) annual Congress, Glasgow 22-25 March, 2015.
Stock J
Atherosclerosis; 2015 Sep; 242(1):45-7. PubMed ID: 26177273
[No Abstract] [Full Text] [Related]
18. Novel risk factors for atherosclerosis.
von Eckardstein A
JAMA; 2004 Jan; 291(3):301; author reply 301-2. PubMed ID: 14734585
[No Abstract] [Full Text] [Related]
19. [Lipoprotein (a), a cardiovascular risk factor: importance of its determination in current clinical practice].
Couderc R; Maachi M
J Mal Vasc; 1998 Jun; 23(3):165-75. PubMed ID: 9669219
[TBL] [Abstract][Full Text] [Related]
20. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.
Wollesen F; Dahlén G; Berglund L; Berne C
Diabetes Care; 1999 Jan; 22(1):93-8. PubMed ID: 10333909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
